Deconstructing the Illinois Research and Development Tax Credit (35 ILCS 5/201(k))
35 ILCS 5/201(k) authorizes a nonrefundable state income tax credit, equal to 6.5% of the increase in qualified research expenditures (QREs) conducted in Illinois, designed to incentivize sustained R&D investment within the state. This credit provides a critical incentive for both new and established businesses engaged in innovation, directly reducing their income tax liability against income earned in or as a resident of Illinois.
The Research and Development (R&D) Tax Credit is a cornerstone of Illinois’s fiscal policy designed to promote local economic growth and technological advancement. As a provision within the Illinois Income Tax Act (IITA), Section 201(k) specifies the scope, eligibility, and calculation methodology, tying the state benefit directly to incremental research spending above a historical average. Compliance requires meticulous tracking of Illinois-sourced activities, strict adherence to Department of Revenue (IDOR) schedules, and an understanding of the relationship between state and federal tax codes.
I. Statutory Foundation: Decoding 35 ILCS 5/201(k)
The structure of the Illinois R&D credit is dictated by the precise language found in the Illinois Compiled Statutes (ILCS), placing it firmly within the framework of state income taxation.
A. Context within the Illinois Income Tax Act (IITA)
The Illinois Income Tax Act (35 ILCS 5/201) imposes a tax measured by net income on individuals, corporations, trusts, and estates for the privilege of earning income in or as a resident of the state.1 Subsection (k) carves out the R&D credit as an offset against this primary liability.
The statute allows a taxpayer a credit against the tax imposed by subsections (a) (individual income tax) and (b) (corporate income tax) for increasing research activities in Illinois.1 This credit is nonrefundable, meaning that while it can reduce the taxpayer’s state income tax liability to zero, any unused credit cannot be claimed as a cash refund. However, the nonrefundable nature is mitigated by robust carryforward provisions, allowing unused amounts to be applied against future tax liabilities.
B. Legislative Intent and Current Horizon
The R&D credit has been subject to periodic legislative review, reflecting its status as an economic incentive. The credit was initially available for tax years ending after July 1, 1990, but subsequently experienced a sunset period between the end of 2003 and December 31, 2004, when it was reinstated.1
Crucially, recent legislative action has secured the long-term availability of this incentive. In accordance with Public Act 103-0595, the Research and Development tax credit has been explicitly extended until tax years ending on or before December 31, 2031.2 This explicit legislative extension of the R&D credit for an extensive period demonstrates a powerful commitment by the state to fostering a stable innovation environment. Taxpayers engaged in strategic tax planning may therefore view this credit as a reliable, long-term economic pillar, allowing for robust multi-year capital commitments to Illinois R&D operations with confidence in future credit realization.
C. Eligibility and Pass-Through Entity (PTE) Rules
While the credit is available to all entities subject to the IITA, specific rules govern how the credit is distributed to the owners of pass-through entities (PTEs) like partnerships and S corporations.1 Recent statutory amendments have altered the allocation mechanism for these entities, requiring specialized attention to the relevant tax year.
- Pre-2024 Allocation: For taxable years ending before December 31, 2023, partners and shareholders of S corporations were allowed the credit based on the determination of income and distributive share of income as outlined under Sections 702 and 704 and Subchapter S of the Internal Revenue Code (IRC).3
- Post-2023 Allocation Change: For taxable years ending on or after December 31, 2023, the statute mandates that the provisions of IITA Section 251 apply to the determination of the credit for partners and shareholders of Subchapter S corporations.3
This switch from general federal allocation methods (IRC 702/704) to a state-specific reference (IITA Section 251) fundamentally changes the compliance landscape for PTEs. IITA Section 251 often standardizes flow-through rules for state-specific tax benefits, indicating that IDOR is moving toward a uniform state-level mechanism for distributive share credits. Tax professionals and PTE administrators must adopt a bifurcated approach to R&D credit allocation, ensuring that the appropriate state or federal mechanism is applied based on whether the tax year ends before or after the December 31, 2023, cutoff date.
II. Defining Qualified Research Expenditures (QREs)
To qualify for the Illinois credit under 35 ILCS 5/201(k), expenditures must satisfy two requirements: first, they must qualify under federal IRC Section 41, and second, they must be strictly sourced to Illinois activities.
A. Federal Conformity and Qualified Activities
The definition of qualifying research activities in Illinois largely conforms to the federal definition established under IRC Section 41. This requires activities to satisfy the four-part test (e.g., elimination of uncertainty, technological in nature, process of experimentation). Once the activity is deemed qualified, the related expenditures must fall into specific categories:
- Wages for qualified services.
- Cost of supplies used in qualified research.
- Rental or lease costs of computers used in qualified research.
- Contract expenses (only 65% of the cost is includible).4
- Basic research payments to qualified organizations (this category is applicable only to corporations).5
These categories are enumerated in IDOR compliance forms and the Illinois Administrative Code (86 Ill. Admin. Code 100.2160), emphasizing the direct connection between the state credit and the federal definition of research.4
B. The “Illinois-Sourced” Mandate
The most critical distinction between the Illinois R&D credit and its federal counterpart is the strict sourcing requirement. To be counted toward the 35 ILCS 5/201(k) credit, QREs must be directly tied to research activities physically performed in Illinois.4
For businesses operating across multiple states, this mandates a detailed allocation process. QREs, particularly wages and contract expenses, must be allocated to Illinois based on documented time and effort spent performing qualified services within the state boundaries.6 This absolute sourcing requirement necessitates precise, state-specific record-keeping that often differentiates the Illinois calculation from the federal calculation, where sourcing rules might be broader or based on a higher percentage threshold.
III. The IDOR Administrative Framework and Guidance
The Illinois Department of Revenue (IDOR) administers the credit through specific regulations and mandatory filing schedules, which clarify the intricacies of the calculation, particularly concerning the base period.
A. Regulatory Implementation (86 Ill. Admin. Code 100.2160)
The IDOR’s regulations provide essential guidance for calculating and claiming the credit. These rules address continuity of credit claims for corporations undergoing certain transactions. For instance, in the case of a taxable year after a taxpayer succeeds to the tax items of a prior corporation under IITA Section 405(a) (consistent with IRC Section 381), the qualifying expenditures incurred by the predecessor corporation during the base period must be deemed the qualifying expenditures of the successor taxpayer.7
Perhaps the most favorable administrative rule for new or expanding businesses relates to the treatment of a base period with no research activity. If a taxpayer incurred no qualifying expenditures during a base period year—either because the taxpayer was not in existence or was not conducting any R&D business in Illinois—the qualifying expenditures for that specific base year are definitively zero.7
This application of the zero-QRE rule is a deliberate, highly beneficial feature for new or expanding businesses entering the Illinois market. Since the credit is inherently incremental (current year expenditures minus the 3-year historical average), using zero values for any prior years where a company had no Illinois activity mathematically guarantees a lower base average. This design ensures that the initial credit available is maximized when the company first begins incurring substantial QREs in the state, clearly demonstrating the state’s intention to reward new and aggressive R&D investment within its borders.
B. IDOR Compliance Reporting and Forms
IDOR enforces the calculation methodology through a mandatory sequence of tax forms, ensuring standardized and consistent credit claims across all taxpayers.
- The Calculation Worksheet (Schedule 1299-I): This worksheet is the essential tool for quantifying the credit earned in the current year.5 It organizes the necessary data, requiring taxpayers to list expenses into the required statutory categories and perform the base period comparison required by 35 ILCS 5/201(k).5
- The Reporting Forms: Once the credit is quantified on Schedule 1299-I, it is reported on the taxpayer’s respective liability schedule using Credit Code 5340.8 Individuals use Schedule 1299-C 8, while corporations and fiduciaries use Schedule 1299-D.5 Taxpayers must round dollar amounts on Schedule 1299-C to whole dollars.9
- Documentation and Audit: Taxpayers must retain robust documentation, including completed worksheets and supporting records, for audit defense.5 Industry guidance emphasizes that five-year records are necessary to verify historical QREs used in the calculation, which covers the entire look-back period required by the incremental method.6
It is important to recognize that while IDOR publishes Informational Bulletins regarding tax law changes 2, the primary guidance for compliance—the detailed mechanical steps—is embedded directly within the form instructions and the Schedule 1299-I worksheet.5 Consequently, mastering the line-by-line structure of the mandated forms is paramount for accurate compliance, often overshadowing generic published guidance in practical application.
IV. The Calculation Mechanism: The Incremental Fixed-Base Method
Illinois exclusively relies on a traditional incremental methodology for the R&D credit, requiring a comparison of current-year spending to a rolling historical average.
A. The Credit Rate and Prohibition of Alternative Methods
The credit allowed against the Illinois income tax is equal to $\mathbf{6.5\%}$ of the increase in qualified research expenditures.4
The calculation must adhere strictly to the 3-year incremental formula prescribed by the statute and regulations. A critical distinction of the Illinois regime is the prohibition of alternative credit methods. Illinois does not offer the use of simplified methodologies, such as the federal Alternative Simplified Credit (ASC) or other fixed-base percentage options.6 Taxpayers are required to use the 3-year average of Illinois-sourced QREs.6
The decision to prohibit simplified methods imposes a practical compliance burden on multi-state companies. It necessitates maintaining two parallel, distinct R&D credit calculations—one for federal purposes (which might utilize the ASC for speed and simplicity) and one for Illinois (which must use the mandatory 3-year incremental method)—all while ensuring that the Illinois calculation only includes Illinois-sourced QREs.6 This rigidity underscores the need for robust internal record-keeping that can differentiate data based on strict geographic sourcing.
B. Step-by-Step Calculation Methodology (Schedule 1299-I)
The calculation measures the excess of current-year QREs over the 3-year average of QREs from the three immediately preceding tax years. This structure is required by 35 ILCS 5/201(k) and implemented through the Schedule 1299-I methodology.4
- Identify Base Period QREs: Determine the total qualifying, Illinois-sourced expenditures for each of the three taxable years immediately preceding the current claim year. As noted, if the taxpayer was not conducting R&D in Illinois during any of these years, the QREs for that year are zero.7
- Calculate Base Amount: Sum the QREs from the three base period years and divide the total by three to find the average. This resulting figure is the Base Period Average QREs (Column A total on Schedule 1299-I).4
- Determine Current Year QREs: Sum the qualifying, Illinois-sourced expenditures for the current taxable year (Column B total on Schedule 1299-I).5
- Calculate Excess QREs: Subtract the Base Amount (Step 2) from the Current Year QREs (Step 3). The difference represents the increase in research activities defined by the statute.4
- Calculate Credit Earned: Multiply the Excess QREs by the 6.5% credit rate (0.065).4
The essential structure of the calculation worksheet is summarized in Table 1, showing the necessary comparison between the historical average and current spending.
Table 1.
Illinois R&D Credit Calculation Structure (35 ILCS 5/201(k) Methodology)
| Expense Category (Illinois-Sourced) | Column A: Base Period Average | Column B: Current Year Expenditures |
| Wages for Qualified Services | Average of 3 prior years | Current year total |
| Cost of Supplies | Average of 3 prior years | Current year total |
| Computer Rental/Lease Costs | Average of 3 prior years | Current year total |
| Contract Research Expenses (65%) | Average of 3 prior years | Current year total |
| Basic Research Payments (Corporations Only) | Average of 3 prior years | Current year total |
| Total QREs | Total Base Period QREs | Total Current Year QREs |
| Credit Calculation | N/A | (Current Year QREs – Base Period QREs) $\times$ 6.5% |
V. Numerical Example: Quantifying the Illinois R&D Tax Credit
To illustrate the application of the incremental calculation methodology defined by 35 ILCS 5/201(k), consider the tax year 2024 for “InnovateTech Corp.”
A. Scenario Setup and Historical Data
InnovateTech Corp. (a corporation filing Schedule 1299-D) has confirmed that all of the following expenditures are attributable to qualified research physically performed within Illinois.
| Year | Total Illinois QREs | Role in Calculation |
| 2021 (Base Year 1) | $500,000 | Historical base data |
| 2022 (Base Year 2) | $700,000 | Historical base data |
| 2023 (Base Year 3) | $900,000 | Historical base data |
| 2024 (Current Claim Year) | $1,500,000 | Current year expenses |
B. Calculation Workflow for 2024 Claim
The following steps determine the amount of credit earned, which will be entered on Schedule 1299-D, Column F, using Credit Code 5340.
Step 1: Calculate the 3-Year Base Period Average QREs (Base Amount)
The sum of QREs for the three preceding years is calculated:
$$\$500,000 + \$700,000 + \$900,000 = \$2,100,000$$
The base period average is then determined by dividing the sum by three:
$$\text{Base Period Average QREs} = \frac{\$2,100,000}{3} = \mathbf{\$700,000}$$
Step 2: Determine Current Year QREs
The total QREs incurred in 2024 (the current tax year) are $\mathbf{\$1,500,000}$.
Step 3: Calculate Excess Qualified Expenditures
The excess QREs represent the increase in research activities:
$$\text{Excess QREs} = \text{Current Year QREs} – \text{Base Period Average QREs}$$
$$\text{Excess QREs} = \$1,500,000 – \$700,000 = \mathbf{\$800,000}$$
Step 4: Apply the Credit Rate (6.5%)
The tax credit is $6.5\%$ of the excess QREs:
$$\text{Credit Earned} = \$800,000 \times 0.065 = \mathbf{\$52,000}$$
InnovateTech Corp. has earned a $\mathbf{\$52,000}$ R&D tax credit for the 2024 tax year. This nonrefundable amount will be utilized to offset the corporation’s Illinois income tax liability.
VI. Conclusion and Strategic Recommendations
The Illinois Research and Development Tax Credit, authorized by 35 ILCS 5/201(k), is a rigorously structured incentive requiring precise statutory interpretation and administrative execution. The credit’s extension through 2031 provides essential stability for long-term investment decisions, yet complexity remains in the strict adherence to Illinois-sourced incremental spending.
For businesses seeking to maximize the benefit under 35 ILCS 5/201(k), the following strategic considerations are critical:
A. Navigating Statutory Nuance
- Leverage the Incremental Base Rule: Businesses newly establishing or significantly expanding their R&D footprint in Illinois should recognize that the IDOR regulation regarding zero QREs in base years ensures that their initial years of high spending will generate maximum credit value. Strategically timing substantial QREs to years following periods of low or zero Illinois activity will yield the greatest incremental credit benefit.
- Manage PTE Allocation Transition: For pass-through entities, the shift in allocation rules effective December 31, 2023, from federal IRC provisions to state IITA Section 251 requires careful review. Practitioners must verify that the distributive share calculations align with the applicable statute for the relevant tax year to ensure owners receive their proper share of Credit Code 5340.3
B. Compliance and Documentation Protocols
- Maintain Parallel Sourcing Documentation: Due to the rigid prohibition of federal alternative methods and the strict mandate for Illinois-sourced QREs, companies must maintain separate documentation justifying the apportionment of employee wages and contract research costs based on documented time and effort physically spent within the state.6
- Adhere to IDOR Form Structure: The final arbiter of compliant claims is the Schedule 1299-I worksheet. Tax planning must begin with the structure of this form, ensuring that data is collected specifically for the required expense categories (wages, supplies, 65% of contract research, etc.) and for the correct five-year look-back period (current year plus three base years, plus one additional year for audit defense).5
- Ensure Audit Readiness: The statute’s reliance on a three-year historical average necessitates maintaining five years of detailed QRE records. Failure to produce verifiable historical data upon audit can compromise the calculation of the base amount and jeopardize the current year’s credit claim.6
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










